Article Versions Notes

Talami A, Bettelli F, Pioli V, Giusti D, Gilioli A, Colasante C, Galassi L, Giubbolini R, Catellani H, Donatelli F, et al. How to Improve Prognostication in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring. Biomedicines. 2021; 9(8):953. https://doi.org/10.3390/biomedicines9080953

Talami, Annalisa, Francesca Bettelli, Valeria Pioli, Davide Giusti, Andrea Gilioli, Corrado Colasante, Laura Galassi, Rachele Giubbolini, Hillary Catellani, Francesca Donatelli, and et al. 2021. "How to Improve Prognostication in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring" Biomedicines 9, no. 8: 953. https://doi.org/10.3390/biomedicines9080953

Talami, A., Bettelli, F., Pioli, V., Giusti, D., Gilioli, A., Colasante, C., Galassi, L., Giubbolini, R., Catellani, H., Donatelli, F., Maffei, R., Martinelli, S., Barozzi, P., Potenza, L., Marasca, R., Trenti, T., Tagliafico, E., Comoli, P., Luppi, M., & Forghieri, F. (2021). How to Improve Prognostication in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring. Biomedicines, 9(8), 953. https://doi.org/10.3390/biomedicines9080953